Novartis will launch a product for hepatitus B this year as it is China\\\'s prevalent disease with approx 20 million affected. CEO Vasella says they have been growing by 20% on average over the last 5 years and gained considerable market share.

Novartis will launch a product for hepatitus B this year as it is China\\\'s prevalent disease with approx 20 million affected. CEO Vasella says they have been growing by 20% on average over the last 5 years and gained considerable market share. He said China\\\'s pharma sector will grow to about $25 billion USD by 2010 from $12 billion now. They also announced they will invest $100 million in R & D in China with no specific timeframe